Your browser doesn't support javascript.
loading
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.
Cho, Hyungwoo; Yoon, Dok Hyun; Lee, Jung Bok; Kim, Sung-Yong; Moon, Joon Ho; Do, Young Rok; Lee, Jae Hoon; Park, Yong; Lee, Ho Sup; Eom, Hyeon Seok; Shin, Ho-Jin; Min, Chang-Ki; Kim, Jin Seok; Jo, Jae-Cheol; Kang, Hye Jin; Mun, Yeung-Chul; Lee, Won Sik; Lee, Je-Jung; Suh, Cheolwon; Kim, Kihyun.
Afiliação
  • Cho H; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee JB; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim SY; Division of Hematology-Oncology, Department of Internal Medicine, Konkuk University School of Medicine, Konkuk University, Seoul, South Korea.
  • Moon JH; Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu, South Korea.
  • Do YR; Department of Hemato-Oncology, Keimyung University Dongsan Medical Center, Daegu, South Korea.
  • Lee JH; Division of Hematology/Oncology, Gachon University Gil Medical Center, Incheon, South Korea.
  • Park Y; Division of Hematology-oncology, Department of Internal Medicine, Korea University School of Medicine, Seoul, South Korea.
  • Lee HS; Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea.
  • Eom HS; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang-si, South Korea.
  • Shin HJ; Department of Internal Medicine, Pusan National University Hospital, Busan, South Korea.
  • Min CK; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Kim JS; Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea.
  • Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Kang HJ; Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
  • Mun YC; Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, South Korea.
  • Lee WS; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, South Korea.
  • Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea.
  • Suh C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim K; Division of Hematology/Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.
Am J Hematol ; 92(12): 1280-1286, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28833417

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article